Advanced Filters
noise

a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Found 10,668 clinical trials
S Susie Zaborszky

A Study of Idazoxan in Healthy Participants

Four-part study of the safety, tolerability and pharmacokinetics of 3 forms of TR-01-XRR, 1 form of TR-01-XRS, and 1 form of TR-01-XR in healthy adults.

18 - 55 years of age All Phase 1
L Luk Buyse, Msc. dr.

A Psychophysiological Database of Maximal Effort Tests.

The aim of this study is first to construct a database containing psychophysiological data from athletes performing a maximal effort test. Second, the investigators want to use the data to optimize the methodological approach during, and trainings advice after maximal effort tests.

18 - 65 years of age All Phase N/A

Uterus Transplantation Procedure From a Live Donor

Absolut uterine factor, meaning the absence of uterus, represents a cause for sterility without the possibility of a present treatment. The uterine factor affects millions of women and may be due to congenital problems, such as the Muller anomalies (Mayer Rockitansky Syndrome) or acquired by previous hysterectomy or intrauterine adhesions …

18 - 65 years of age Female Phase N/A
O Olof Molander

iCBT for GD and Comorbidities - a Pilot

The study is a pilot study (Total N=30), with at pre, weekly during treatment, post and at three-month follow-up.

18 years of age All Phase N/A
P PharmaLex Japan Inc.

A First-in-Human Study of PRD001

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of PRD001 in healthy participants and to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of PRD001 in participants with borderline/mild hyper-LDL-cholesterolemia and mild fatty liver.

18 - 60 years of age Male Phase 1
V Victor Tellez

A Trial of Selinexor, Ruxolitinib and Methylprednisolone

Selinexor, a first-in-class, oral selective exportin 1 (XPO1) inhibitor, has shown promise in pre-clinical and clinical studies. It functions by inhibiting the nuclear export protein XPO1, resulting in the accumulation of tumor suppressor proteins and inhibition of oncoprotein mRNAs, which is selectively lethal to myeloma cells. Selinexor has demonstrated activity …

years of age All Phase 1

A Study of LY3867070 in Healthy Participants

The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the …

18 - 65 years of age All Phase 1

A Phase Ib Study of RC1416 Injection

This is a Phase Ib study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RC1416 injection in patients with moderate to severe asthma.

18 - 75 years of age All Phase 1
N Nucleus Network, Melbourne

A Phase 1 Study of PROT-001.

A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled 3 Part Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of PROT-001, and the Effect of Food and Age on the Pharmacokinetics of PROT-001 in Healthy Adult Participants

18 - 75 years of age All Phase 1
S Seth Price

A Study of IBI3032 in Healthy Participants

This is a randomized, double-blind, placebo-controlled Phase I clinical study evaluating the safety, tolerability, and PK of a single dose of IBI3032 in healthy participants. This is a single ascending dose (SAD) study. Approximately 32 healthy participants are expected to be enrolled in this study. The screening period is 4 …

18 - 65 years of age All Phase 1

Simplify language using AI